Clinical Trial Update: BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for BNC105P combined with everolimus in progressive metastatic clear cell renal cell carcinoma; phases 1 and 2 completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• BNC105P (BNC105P)
• Everolimus (everolimus)

Snippet

Sponsor: Hoosier Cancer Research Network | Conditions: Renal Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-05-24